Acta Med. 2007, 50: 203-206

https://doi.org/10.14712/18059694.2017.83

Evaluation of Potency of Known Oximes (Pralidoxime, Trimedoxime, HI-6, Methoxime, Obidoxime) to in vitro Reactivate Acetylcholinesterase Inhibited by Pesticides (Chlorpyrifos and Methylchlorpyrifos and Nerve Agent (Russian VX)

Kamil Musíleka,b, Kamil Kučab,c, Daniel Junb,c

aCharles University in Prague, Faculty of Pharmacy in Hradec Králové, Department of Pharmaceutical Chemistry and Drug Control, Hradec Králové, Czech Republic
bUniversity of Defence, Faculty of Military Health Sciences, Department of Toxicology, Hradec Králové, Czech Republic
cUniversity of Defence, Faculty of Military Health Sciences, Centre of Advanced Studies, Hradec Králové, Czech Republic

Received March 1, 2007
Accepted July 1, 2007

References

1. Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 2004; 38:151–216. <https://doi.org/10.1016/S0065-2423(04)38006-6>
2. Ekstrom F, Akfur C, Tunemalm K, Lundberg S. Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase. Biochemistry. 2006; 45:74–81. <https://doi.org/10.1021/bi051286t>
3. Gupta R. Toxicology of organophosphate & carbamate compounds. In: Global epidemiology of organophosphate and carbamate poisonings. Elsevier Academic Press, London, pp. 89–102.
4. Kassa J. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol. 2002; 40:803–816. <https://doi.org/10.1081/CLT-120015840>
5. Kassa J, Kuča K, Cabal J. Comparison of the efficacy of currently available oximes against tabun in rats. Biologia 2005; 60:79–81.
6. Kuča K, Patočka J, Cabal J. Reactivation of organophosphate inhibited acetylcholinesterase activity by α,ω-bis-(4-hydroxyiminomethylpyridinium)alkanes in vitro. J Appl Biomed. 2003; 1:207–11.
7. Kuča K, Pícha J, Cabal J, Liška F. Synthesis of the three monopyridinium oximes and evaluation of their potency to reactivate acetylcholinesterase inhibited by nerve agents. J Appl Biomed. 2004; 2:51–56.
8. Kuča K, Cabal J. Evaluation of newly synthesized reactivators of the brain cholinesterase inhibited by sarin-nerve agent. Toxicol Mech Method. 2005; 15: 247–52. <https://doi.org/10.1080/15376520590968770>
9. Kuča K, Cabal J, Musílek K, Jun D, Bajgar J. Effective bisquaternary reactivators of tabun-inhibited AChE. J Appl Toxicol. 2005; 25:491–5. <https://doi.org/10.1002/jat.1084>
10. Kuča K, Cabal J, Jun D, Kassa J, Bartošová L, Kunešová G. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions. J Appl Toxicol. 2005; 25:296–300. <https://doi.org/10.1002/jat.1065>
11. Kuča K, Jun D, Musílek K. Structural requirements of acetylcholinesterase reactivators. Mini-Rev Med Chem. 2006; 6:269–77. <https://doi.org/10.2174/138955706776073510>
12. Marrs TC. Organophosphate poisoning. Pharmacol Ther. 1993; 58:51–66. <https://doi.org/10.1016/0163-7258(93)90066-M>
13. Musílek K, Kuča K, Jun D, Dohnal V. Doležal M. Synthesis of a novel series of bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. J Enzym Inhib Med. Chem. 2005; 20:409–15. <https://doi.org/10.1080/14756360500179762>
14. Musílek K, Kuča K, Jun D, Dohnal V, Doležal M. Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2–ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. Bioorg Med Chem Lett. 2006; 16:622–7. <https://doi.org/10.1016/j.bmcl.2005.10.059>
15. Musílek K., Lipka L., Račáková V., Kuča K., Jun D., Dohnal V., Doležal M. New methods in synthesis of acetylcholinesterase reactivators and evaluation of their potency to reactivate cyclosarin-inhibited AChE. Chem Pap. 2006; 60:48–51. <https://doi.org/10.2478/s11696-006-0008-x>
16. Tattersall JE. Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro. Br J Pharmacol. 1993; 108:1006–15. <https://doi.org/10.1111/j.1476-5381.1993.tb13498.x> <PubMed>
17. Taylor P. Anticholinergic agents. In: The Pharmacological Basis of Therapeutics. 2001;Hill, New York, pp. 175–91.
18. Thiermann H, Szinicz L, Eyer F, Worek F, Eyer P, Felgenhauer N, Zilker T. Modern strategies in therapy of organophosphate poisoning. Toxicol Lett. 1999; 107:233–9. <https://doi.org/10.1016/S0378-4274(99)00052-1>
19. Worek F, Thiermann H, Szinicz L, Eyer P. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem Pharmacol. 2004; 68:2237–48. <https://doi.org/10.1016/j.bcp.2004.07.038>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive